A SECOND Covid-19 vaccine was endorsed by a government advisory panel on Thursday, as the US surpassed 17million cases.
The Food and Drug Administration (FDA) advisory panel voted 20-0 that benefits of the vaccine by Moderna and the National Institutes of Health outweighed the risks.
The FDA is expected to approve Moderna’s vaccine for emergency use quickly, allowing the company to start shipping millions of doses.
Pfizer and BioNTech’s vaccine began shipping across the US on Sunday, and health care workers have already received the shot.
